Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.

Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J Exp Med. 1982 Oct 01; 156(4):1000-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.